Development and validation of serological markers for detecting recent Plasmodium vivax infection - Longley, Rhea J.; White, Michael T.; Takashima, Eizo; Brewster, Jessica; Morita, Masayuki; Harbers, Matthias; Obadia, Thomas; Robinson, Leanne J.; Matsuura, Fumie; Liu, Zoe S. J.; Li-Wai-Suen, Connie S. N.; Tham, Wai-Hong; et al. (Nature Medicine, 2020)
Keywords: 631/326/417/2546; 692/308/174; 692/308/575; 692/699/255/1629; 706/134; Adult; Antibodies; Antigens; Asymptomatic; Biological markers; Biomarkers; Biomarkers - blood; Biomedical and Life Sciences; Biomedicine; Brazil - epidemiology; Cancer Research; Child; Cohort Studies; Control; Diagnosis; Early Diagnosis; Health services; Human health and pathology; Humans; IgG antibody; Immunoglobulin G; Immunoglobulin G - analysis; Immunoglobulin G - blood; Infection Control - methods; Infections; Infectious Diseases; Life Sciences; Liver; Longitudinal Studies; Malaria; Malaria, Vivax - blood; Malaria, Vivax - diagnosis; Malaria, Vivax - epidemiology; Mathematical models; Medical research; Medicine; Melanesia - epidemiology; Metabolic Diseases; Methods; Molecular Medicine; Neurosciences; Parasites; Plasmodium vivax; Plasmodium vivax - physiology; Prevalence; Proteins; Sensitivity and Specificity; Serodiagnosis; Serologic Tests - methods; Serologic Tests - standards; Serology; Testing; Thailand - epidemiology; Time Factors; Toolkits; Brazil; Thailand; Melanesia; Solomon Islands